Purchase Order 75N95019P00451
Award Date 7/23/19
Potential Completion Date 10/15/19
Potential Value $97K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
France
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>
- This federal contract award, identified as 75N95018P00712, was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Molport SIA, a for-profit limited liability company located in Latvia. The contract, valued at $51,771.73, is for the purchase of a Chemical Library of 216 small molecule compounds. The contract is a firm fixed-price purchase order with an ultimate completion date of January 31, 2019. The contract was awarded on September 20, 2018, following a pre-solicitation...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,000.00 firm-fixed-price purchase order to ChemDiv, Inc. to provide a compound library of 8,000 specific and unique small molecule compounds. The compounds are being procured for the National Center for Advancing Translational Sciences (NCATS) to support their Genesis screening library. The contract does not have a set-aside designation, and the place of performance is San...
- This is a $80,400.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Axon Medchem B.V., a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which aims to provide small molecule compounds. The contract has an ultimate completion date of July 25, 2015 and was awarded on April 24, 2015. There was no set-aside designation used for...
- <p>The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $452,500.00 firm fixed-price purchase order contract to Chemroutes Corporation, a foreign-owned for-profit organization, for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract has an ultimate completion date of April 30, 2016 and was awarded on December 23, 2015. This contract was not set aside for any particular business type.</p>
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
- <p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
- The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
- This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...